Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium

September 4, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today shared key takeaways from its standing-room-only symposium with about 400 attendees, "Pain Management, RE-Invented: A New Era for Analgesia", held September 3, 2025, at PAINWeek in Las Vegas-the world's largest pain management...

Read more

Shawn Wells Joins Tonum Health's Scientific and Strategic Advisory Board

September 4, 2025 7:04 AM

Tonum Health, a developer of science-backed natural supplements for cognitive performance, weight loss, and metabolic health, is proud to announce that Shawn Wells, MPH, RD, LDN, CISSN, FISSN, has joined the company's Scientific and Strategic Advisory Board. Known internationally as "The World's Greatest Formulator" and "The Most Trusted Voice in Supplements," Wells brings over 25 years of expertise in nutritional biochemistry, clinical...

Read more

Military Veterans Join Virtue Recovery to Expand Community Outreach With Hope and Support

September 4, 2025 6:00 AM

Virtue Recovery has expanded its Business Development Team with the addition of two U.S. military veterans: Adam Khosroabadi, U.S. Marine Corps Veteran, and Chauncy Nash, U.S. Army Veteran. Their combined military service, healthcare expertise, and personal recovery journeys strengthen Virtue Recovery's mission to support individuals and families struggling with addiction, PTSD, and mental health challenges.Strengthening Outreach Through...

Read more

DEA Marijuana Decision Showtime: MMJ Issues Demand Letter on DEA

September 4, 2025 5:00 AM

Newly confirmed DEA Administrator Terrance "Terry" Cole faces a defining first decision: Will he break from the DEA's long history of obstructing medical cannabis research, or will he side with entrenched bureaucrats accused of stifling science and patient care? At the center of this test is MMJ BioPharma Cultivation, Inc., a company that has spent more than seven years seeking DEA approval to cultivate pharmaceutical grade cannabis for FDA...

Read more

Data from AlzeCure's Pain Project ACD440 Presented at the NeuPSIG 2025 Pain Conference

September 4, 2025 4:20 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that its presentation at the international pain conference NeuPSIG 2025 is now available in full on the company website. The presentation includes data from the Phase II clinical study with the company's lead clinical drug candidate in pain,...

Read more

IRLAB Is Granted a Patent Strengthening the Market Exclusivity of The Drug Candidate Mesdopetam in China

September 4, 2025 1:20 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company has been granted an additional ‘composition of matter patent' in China. The patent protects the salt of mesdopetam intended for use in the forthcoming pharmaceutical product and the process of its manufacture. The now granted patent expands the already strong patent protection for...

Read more

National Brain Tumor Society Appoints Renowned Pediatric Oncologist Dr. Susan Blaney as Chief Scientific Officer

September 3, 2025 4:10 PM

National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, is proud to announce the appointment of Susan Blaney, MD, as its new Chief Scientific Officer (CSO), effective September 2025, during Childhood Cancer Awareness Month.Dr. Blaney brings decades of leadership in pediatric oncology and neuro-oncology research to NBTS, further strengthening the organization's strategic efforts...

Read more

BookJane Unveils Automated Scheduling Intelligence: The Future of Workforce Management

September 3, 2025 2:00 PM

BookJane, a leading workforce management platform, today announced the launch of its new Automated Scheduling Intelligence, a breakthrough solution designed to simplify even the most complex workforce planning needs.With Automated Scheduling Intelligence, organizations can now build and manage schedules across hospitals, senior living, retirement homes, and other shift-based industries with unprecedented speed and accuracy. Leaders can plan...

Read more

DaVita Marks Major Milestone in 100% Renewable Energy Commitment

September 3, 2025 11:55 AM

DaVita has taken a major step toward its goal of having 100% of its worldwide operations powered by renewable energy. As of July 1, the kidney care leader is now matching its global electricity use with clean energy through renewable energy credits and strategic power agreements - including a new solar collaboration in Spain that brings the company closer to a greener future.This milestone is supported by strategic virtual power purchase...

Read more

Allstar Global Brands Partners with MAS + DRINK AT Milton Soccer for USA Cup Qualifier in Late August

September 3, 2025 10:00 AM

Allstar Global Brands is proud to announce an exciting partnership with Milton Soccer to sponsor and support their involvement in the USA Cup Qualifier scheduled for late August. This collaboration marks a significant step forward in fostering youth soccer development, leveraging cutting-edge technology, and inspiring the next generation of athletes to excel on and off the field.As part of this partnership, Milton Soccer will integrate Allstar...

Read more

Exousia Pro Creates New Subdivisions

September 3, 2025 9:45 AM

Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of cancer and other diseases, has filed with the State of Florida a new subsidiary to act as our operations holding company, Exousia Pro Holding Management, LLC ("EPHM"), for our three newly created divisions.EPHM shall own 100% of Exousia Ai, Inc., 100% of Exousia Health, Inc., and Exousia Wholesale, Inc. As we expand the...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Launches AI Wound Monitoring Tool for $20+ Billion Chronic Care Market

September 3, 2025 9:35 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced its AI-powered Wound Monitoring System, designed to provide real-time wound care diagnostics using only smartphone imagery.The platform applies sequential imaging algorithms, automated edge detection, and infection risk modeling to track wound healing trajectories and flag early signs of infection or stagnation. This capability offers a disruptive alternative to expensive, in-person...

Read more

Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity

September 3, 2025 9:20 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has received a notice to exercise warrants over 250,000 new ordinary shares in the Company (the "Warrant Shares").The Warrant Shares are being issued pursuant to the exercise of warrants granted and announced on 8 May 2025. As announced, the exercise price of the warrants ("Exercise Price") is subject to adjustment in certain circumstances, as set out in the warrant instrument, including...

Read more

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

September 3, 2025 9:15 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it will present at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025 in New York, NY.In addition to the presentation, management will be available to participate...

Read more

Onvida Health and Ambience Healthcare Launch Frontier Ambient AI Capabilities Inside Epic

September 3, 2025 9:05 AM

SAN FRANCISCO, CA and YUMA, AZ / ACCESS Newswire / September 3, 2025 / Onvida Health and Ambience Healthcare today announced the launch of frontier ambient AI capabilities directly inside Epic's Hyperspace and Haiku applications. This enterprise-wide deployment gives Onvida clinicians seamless access to Ambience's chart summarization, ambient scribing, coding, and patient summary technology - all without ever leaving Epic.Building on their...

Read more

PSF Dental Reinforces Market Leadership With High-Quality Dental Equipment at Unbeatable Prices

September 3, 2025 9:00 AM

PSF Dental, a trusted global supplier of innovative dental solutions, today announced its renewed commitment to providing High-Quality Dental Equipment at Unbeatable Prices, reinforcing its leadership in the dental marketplace.With a strong portfolio of advanced diagnostic devices, imaging systems, treatment units, and sterilization solutions, PSF Dental continues to empower dental practitioners worldwide with the tools they need to enhance...

Read more

ACOFP Foundation's Family Medicine Forward Campaign Funds Expanded Programs for Early Career Physicians

September 3, 2025 9:00 AM

The American College of Osteopathic Family Physicians (ACOFP)'s Family Medicine Forward campaign, in its second year, is already making a difference for early career osteopathic family physicians. The campaign aims to provide expanded leadership development support as well as address critical barriers within the profession, including increased representation in our communities and enhanced patient support. The campaign is currently about...

Read more

CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference

September 3, 2025 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced that David Cory, CEO, will present a company update at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025 at 10:00 AM ET.CASI will also host one-on-one meetings with investors at the conference.About CASI...

Read more

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

September 3, 2025 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced positive final results from its randomized, crossover bioavailability trial to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of Aspire's investigational new sublingual aspirin product compared to chewed uncoated aspirin tablets in healthy adults. The...

Read more

"Ozempi-Tuck": Dr. Joshua Hyman's Tummy Tuck Solution for Patients After Rapid Weight Loss

September 3, 2025 8:00 AM

With the popularity of weight-loss medications like Ozempic® and Wegovy® on the rise, a new trend is emerging in plastic surgery circles: the "Ozempi-tuck." Patients experiencing rapid weight loss are turning to board-certified plastic surgeon Dr. Joshua Hyman for expert tummy tuck procedures to remove the loose, sagging skin left behind."Ozempi-Tuck" may sound playful, but the need is serious. Many individuals who achieve significant weight...

Read more